‘Over-Reporting’ An ‘Inherent Risk’ In Self-Report Study – Oral Contraceptive OTC Switch Sponsor

HRA Says Results Supporting Safe OTC Not Affected While Cause ‘Incompletely Understood'

HRA says its research in support of its sNDA for its 0.75-mg norgestrel tablet branded Opill shows accurate OTC self-selection and safe use of the progestin-only drug by females of reproductive age.

• Source: Shutterstock

The volume of HRA Pharma’s research information for its proposal for the first OTC switch of a daily oral contraceptive in the US will be weighed against Food and Drug Administration concerns including actual use study results showing some participants reported using more doses than they received.

In its briefing material for the FDA’s Nonprescription Drug and the Obstetrics, Reproductive and Urologic Drugs advisory committees’ meeting...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

Women’s Health: Tranexamic Acid Now Available OTC In France

 
• By 

Cemag Care may be behind the recent Rx-to-OTC switch of menstrual health treatment tranexamic acid (1000mg) in France.

Perrigo: Women’s Health Innovation Must Involve Women, Right From The Start

 
• By 

“Women's health isn't a niche area," noted Perrigo’s Alison Slingsby at Lynx2Market’s PharmaSynergyOTC event in Rome. Slingsby offers advice from the firm's experience in delivering some of the most innovative women's health Rx-to-OTC switches.

Opella’s Cialis Set To Become First OTC Erectile Dysfunction Treatment In Japan

 
• By 

Opella's Japanese subsidiary, SSP Pharmaceuticals, has had an Rx-to-OTC switch application for ED drug Cialis approved by the national regulator.

Japan Approves OTC Sale Of Emergency Contraceptive Pill

 
• By 

Aska Pharmaceutical has recieved a green light from Japan’s Ministry of Health, Labour and Welfare for the Rx-to-OTC switch of its NorLevo (1.5mg levonorgestrel) emergency contraceptive. Controversially, OTC NorLevo will need to be taken on the spot by purchasers in the presence of a pharmacist.

More from Health

Over The Counter: Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes

 
• By 

HBW Insight speaks to AESGP's governmental and public affairs manager, Luis Rhodes Baiao, about the association's Self-Care Insight and Inspire platform, which brings together inspiring self-care initiatives from across Europe.

US FDA Facility Inspections, Website Reviews Paused With FY 2026 Budget On Hold

 

Continuing work includes “for cause and certain surveillance inspections of regulated facilities” and “criminal enforcement work and certain civil investigations” as White House mulls layoffs rather than furloughs during federal government shutdown.

PAGB: UK NHS Risks Missed Opportunity If Digital Self-Care Not Urgently Prioritized

 
• By 

The NHS App should direct users to trusted, external OTC brand resources where appropriate, says PAGB in its latest report.